Icu Medical (ICUI) EBIT (2009 - 2026)

Icu Medical's EBIT history runs 18 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly EBIT rose 5.36% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.5 million (down 34.56% YoY) and the FY2025 annual result came in at $42.8 million, changed 0.31% from the prior year.
• EBIT was $13.6 million for Q1 2026 at Icu Medical, up from $5.6 million in the prior quarter.
• Across five years, EBIT topped out at $37.7 million in Q4 2024 and bottomed at -$42.2 million in Q1 2022.
• A 5-year average of $4.7 million and a median of $7.7 million in 2024 frame the typical range for EBIT.
• Peak annual rise in EBIT reached 5850.0% in 2023, while the deepest fall reached 5387.84% in 2023.
• Icu Medical's EBIT stood at -$222000.0 in 2022, then plunged by 5387.84% to -$12.2 million in 2023, then jumped by 409.37% to $37.7 million in 2024, then tumbled by 85.05% to $5.6 million in 2025, then surged by 140.98% to $13.6 million in 2026.
• Business Quant data shows ICUI's EBIT at $13.6 million in Q1 2026, $5.6 million in Q4 2025, and $13.7 million in Q3 2025.